| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dezocine |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Pentazocine lactate (substance) |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Pentazocine hydrochloride |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Phenazocine hydrobromide |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Qualitative measurement of opiate agonist |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Alfentanil measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Alphaprodine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Anileridine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Codeine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Dextromoramide measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Diamorphine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Mersalyl measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Oxycodone measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Methylfentanyl measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Norfentanyl measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| 6-beta-Naltrexol measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| 6-Monoacetylmorphine measurement (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Moricizine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Oxymorphone measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Paramethadione measurement (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Despropionylfentanyl measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Methadone, long acting metabolite measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Oxycodeinone measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Opioid screening |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Methadone measurement, urine |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Urine morphine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Methadone measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Urine codeine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Urine opiate measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Serum morphine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| buprenorfin 300 mikrogram/ml, injektionsvätska, lösning, ampull 1 ml |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull 1 ml |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull 2 ml |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| pentazocin 30 mg/ml, injektionsvätska, lösning, ampull 1 ml |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| pentazocin 30 mg/ml, injektionsvätska, lösning, ampull 2 ml |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Pentazocine (as pentazocine lactate) 50 mg rectal suppository |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| bensomorfanopioid |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Dimethadione measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Opiate agonist-antagonist product |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Butorphanol product |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing precisely butorphanol tartrate 10 milligram/1 milliliter conventional release nasal spray (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Buprenorphine product |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Nalbuphine product |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| butorfanoltartrat 2 mg/ml, injektionsvätska, lösning, ampull |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| butorfanoltartrat 1 mg/ml, injektionsvätska, lösning, ampull |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| nalbufinhydroklorid 20 mg/ml, injektionsvätska, lösning, ampull |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| acetylsalicylsyra + pentazocinhydroklorid 325 mg, tablett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| paracetamol 650 mg + pentazocinhydroklorid 25 mg, kapseltablett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Dextropropoxyphene (substance) |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Dihydrocodeine (substance) |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Phenazocine (substance) |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Dextromoramide (substance) |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Serum methadone level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Urine diamorphine level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Oral fluid opiate level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Oral fluid morphine level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Oral fluid methadone level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Urine methadone metabolite level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing pentazocine (medicinal product) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Meperidine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Dihydromorphinone measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Opiates |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Trimethadione measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Quantitative measurement of opiate agonist |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Nalorphine measurement (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| mätning av dihydrokodeinon |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Morphine measurement, quantitative |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| screening och mätning av morfin |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing butorphanol (medicinal product) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing buprenorphine (medicinal product) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing nalbuphine (medicinal product) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Nalbuphine hydrochloride [central nervous system use] |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Nalbuphine hydrochloride [anesthesia] |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Buprenorphine 70micrograms/hour transdermal patch |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Buprenorphine 52.5micrograms/hour transdermal patch |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Buprenorphine 35micrograms/hour transdermal patch |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Buprenorphine hydrochloride + naloxone hydrochloride |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| buprenorfinhydroklorid 2 mg + naloxonhydroklorid 0,5 mg, resoriblett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| buprenorfinhydroklorid 8 mg + naloxonhydroklorid 2 mg, resoriblett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| buprenorfin 35 mikrogram per timme, depåplåster |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| buprenorfin 52,5 mikrogram per timme, depåplåster |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| buprenorfin 70 mikrogram per timme, depåplåster |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Pentazocine hydrochloride 25 mg oral tablet |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| nalbufinhydroklorid |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| paracetamol 650 mg + pentazocinhydroklorid 25 mg, kapseltablett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| acetylsalicylsyra + pentazocinhydroklorid 325 mg, tablett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| paracetamol + pentazocinhydroklorid |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| naloxonhydroklorid + pentazocinhydroklorid |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| acetylsalicylsyra + pentazocinhydroklorid |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Dihydrocodeine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Urine dihydrocodeine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
| Product containing buprenorphine and naloxone (medicinal product) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|